All Episodes

Introduction to the Canadian Hematology Consensus Group (CHCG)

Double-Exposed CLL/SLL: A Canadian Perspective

Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy

Highlights from EHA/ICML 2025: International Perspective on CLL

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

ASH 2024: Updates on CLL

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape

Highlights from EHA 2024 - Updates on the Treatment of CLL

LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL

Cutting Edge Advances in the Treatment of Lung Cancer

Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers

Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective

Immunotherapy for Kidney Transplant Patients with Skin Cancer

LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM

Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC

First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion

First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion

First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment

First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs

Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyperglycemia

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Skin Reactions

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Introduction to EV

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Peripheral Neuropathy

Live from CCOLD - Treatment of CLL

Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL

Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer

Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL

ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL

Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer

Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301

Immunotherapy for Cervical Cancer

Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist

Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer

Immunotherapy in HNSCC Series: Ep 2 - Perspectives from Surgical Oncology

Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing

Triple Negative Breast Cancer: Immunotherapies and Biomarkers

Precision Medicine in Oncology: Ep.10. Biomarkers in Gastrointestinal Malignancies

Precision Medicine in Oncology: Ep.9 DEBATE - Is PARP inhibitor maintenance therapy in first-line BRCA mutated ovarian cancer a curative-intent strategy?

Precision Medicine in Oncology: Ep.8. Importance of BRCA testing for Advanced Epithelial Ovarian Cancer

Precision Medicine in Oncology Podcast Series: Ep7. Importance of Genetic Testing in Patients with Prostate Cancer

Precision Medicine in Oncology: Ep.6 Biomarker testing in metastatic colorectal cancer – mismatch repair and beyond

Zanubrutinib for the Treatment of Waldenstrom's Macroglobulinemia

Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer

Lung Cancer Screening: Ontario

Lung Cancer Screening: Western Canada

Dépistage du Cancer Du Poumon: Québec

Lung Cancer Screening: National

Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec

Treatment of Relapsed/Refractory Hodgkin's Lymphoma

Chronic Lymphocytic Leukemia (CLL): How do we Manage Patients During COVID-19?

Virtual Patient Management during COVID-19: How can we best Manage Patients with Inflammatory Arthritis?

The Opioid Epidemic in Canada: What Can We Do?

COVID-19: Playing Sports Safely with Dr. Ray Deonandan